Over a decade ago, an idea was born that quantitation of anti-HBc (total, IgG or IgM) can bring further information on the status of immune activation in an infected individual and thus provide additional understanding of the phase of infection, stage of liver disease and sensitivity to treatment [15]. Here, KRT88P is linked to infection.